莫德纳

关于 Moderna

Moderna, engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and为一家企业，主要从事相关业务。 2010年成立。总部位于Cambridge, MA。

成立时间

2010

首席执行官

Mr. Stephane Bancel

员工人数

4,700

总部地址

Cambridge, Massachusetts, United States of America

财年结束日

12-31

官方网站

modernatx.com

公司概况

交易所

US

股票代码

MRNA

市值排名

#406

上市日期

2018-12-07

市值

87.04B

流通市值

81.16B

总股数

399.24M

流通股数

372.26M

行业与主题板块

浏览全部行业与主题板块